Cephpax Migraine Relief is a patented, anti-inflammatory nutraceutical formulation. Cephpax is clinically proven to reduce the severity of migraines by 80% when no prescription medication is being taken. Cephpax also reduced the number of Migraine outbreaks by 50% for those taking prescription medications. Taken daily, the ingredients in Cephpax target the inflammatory mechanisms now thought to trigger the neurologic pain associated with migraine headaches. The components of Cephpax Migraine Relief are recognized as GRAS (generally recognized as safe) under Title 21 Code of Federal Regulations and the Federal Food, Drug and Cosmetic Act. Cephpax Migraine Relief is manufactured in the United States in an FDA-inspected facility. Visit